EquityFlow › Companies › NADMED

NADMED

biotech · Helsinki, FI

Biotech making CE-marked kits measuring NAD and glutathione levels from blood.

Funding history

DateRoundAmount
Aug 2024Series A
NADMED raised a €3.5M Series A led by Nordic Science Investments to enter the US and expand its NAD testing technology.
$3.5M

Investors

Nordic Science InvestmentsVoima Ventures

Similar companies in biotech

Antag TherapeuticsAdcendoFreya BiosciencesTXN SystemsPromise BioConcinnity GeneticsNoema PharmaMabGenesisRadioNano TherapeuticsCitryllAlveron PharmaAQEMIA
Explore funding flow on EquityFlow →